At a recent MIT conference a white paper was presented that suggested the U.S. medical system was in a state of increasing failure. Even worse, the conclusion of the multi-disciplinary study group was that it was not fixable. Any hope would come from initiatives outside the current medical system. Tommy Thompson, the national leader of our healthcare system has recently concluded the same thing.

The only thing I would question is his conclusion that their is a malpractice crisis. With medical error the third leading cause of death in the U.S., one could conclude that there should be significantly more malpractice claims if patients were really aware of the number of medical errors inflicted upon them, and the number of institutions that cover them up.

The American Medical System is Nearing Collapse

By Tommy G. Thompson – U.S. Secretary of Health and Human services

We are living in the most amazing era of medicine in human history. Yet as we all know too well, all is not well with American medicine. In point of fact, we are dealing with a system of healthcare delivery that is, at its root, dysfunctional.

The problem – the crisis – is the system by which care is delivered, which has simply not matured at the same pace as the technologies and treatments now available.

I’ve traveled all over the country. I’ve traveled to Spain and Germany. I’ve been to Canada. I’ve discussed healthcare with some of the leading policymakers and caregivers in the world. And sadly, I have to report that in Western society broadly, the various systems of care are eroding with ever-greater rapidity.

I’ve come to one central conclusion: The way we provide care is in jeopardy of collapse. It is clouded by regulatory burdens that are confusing, duplicative and extremely time-consuming. Physicians and nurses almost have to obtain advanced degrees in business administration, accounting and jurisprudence just to run their offices from day to day. Patients have to fill out endless forms; get transferred from place to place; worry about what insurance will pay for what treatment and at what cost.

We have to fundamentally change the current healthcare delivery system in our country. The myriad rules, regulations and restrictions that make obtaining good healthcare difficult, if not impossible, have to be reviewed carefully and, when necessary, jettisoned like useless ballast.

But there’s another area of reform that must – I repeat, must – be among the highest priorities we can develop: malpractice reform. America is experiencing a medical malpractice insurance coverage crisis that is increasing the cost of healthcare, decreasing access to doctors and hospitals for many patients and lowering the overall quality of care provided to patients.

Tommy G. Thompson is U.S. secretary of health and human services. This is excerpted and condensed from his remarks July 18 in Chicago to the American Medical Association

Repeatable clinical results are the gold standard for any treatment modality. Few published frequency sets for the FSCAN or Rife devices give repeatable results. Some of the few published sets I have seen, such as a list of frequencies for carpal tunnel syndrome, work 90% of the time for me with immediate relief in 10 minutes.

“What works” is of highest priority. Efficient use of research resources is to focus on documenting how and why “what works” is useful and how to assure it is repeatable. Only then can you take a result to clinical trials for definitive comparison to other treatements.

During the past few years, I have had a 100% success rate in eliminating clinical symptoms from parasite infections with careful clinical technique. I could post the frequencies for about two dozen parasites along with comments on clinical symptoms and conclusions about probably route of infection and suspected organism in many cases. Here are the problems:

1. You must know the exact frequencies of each stage of the life cycle of the parasite (typically there are four). They are specific not only to the parasite, but to the strain of the parasite in question. For some parasites, you must be within 10HZ in the Clark frequency range, 2HZ in the Rife range, or you will simple annoy it, not eliminate it. There are many methods that people have used to find exact frequencies but they are all very controversial, even the automated DIRP function on an FSCAN.

2. Zapping any strain of any organism causes evolution of the infectious disease. Most people are aware of this because antibotics have spawned resistant forms. With any set of organisms in the body, different specific organisms respond to a frequency range. Let’s assume the organism response is normally distributed and you hit the “exact” frequency or the mean of the normal distributed frequency band for the organism and wipe out two standard deviations on either side of the mean. The upper 5% and lower 5% still live and grow new populations of organisms outside the range of destruction of the original frequency. This means you must quickly determine a new frequency to terminate another population, and maybe have to do this several times before you are done.

3. You also must be able to detect the organism in any food or clothing which may cause reinfection. Many of the parasites are extremely infectious. A contaminated pair of eyeglasses, or an eyeglass case, or a sock is all that is necessary to spawn a new infection. Until we all have a DNA scanner that will work in a very generic way, prevention is not possible for many people. Thus even perfect clinical techniqe will not solve the problem.

4. Pockets of organisms may hide away in various organ systems. The brain is a favorite place for jock itch or athlete’s foot since the organisms are exposed to many toxic agents on other body parts, but almost noone is foolish enough to plaster their head with Tiniactin. Plate zapping (a la Hulda Clark) with contact electrodes or passing a Rife tube over all parts of the body with the ability to detect (like an airport scanner) any spots where organisms are hiding out is essential. Most people are unable to detect where organisms may be hiding.

5. Even more subtle effects exist. As Aubrey has pointed out, the frequency that affects an organism is distorted by the tissue through which it passes (an effect well known to radiologists) and that must be calibrated for (I spent many years on the faculty of the Department of Radiology at the Univ. of Col School of Medicine where my job was to supervise Ph.D. theses trying to determine and adjust for such effects.) This means the same organism may require different frequencies in different tissues.

6. Killing a parasite will often release other organisms that must be identified as to frequency and killed quickly. Otherwise the treatment can sometimes be worse than the disease. I once precipitated a gall bladder attack in myself with four cascading sets of organisms. I was able to identify the frequencies and kill all of them within 20 minutes. Going from a full blown gall bladder attack to perfectly health in 20 minutes was extremely painful and very scary. Not recommended for the faint of heart.

7. Every person I have tested has multiple parasite infections, some of them there since birth or early youth, often with no clinical symptoms. All of them I view as clinical time bombs since any compromise of the immune system can cause one or more of them to grow exponentially. It takes a lot of time to figure out how to deal with this.

8. A co-infection, like candida, can make it impossible to eliminate the parasite without eliminating the candida. The parasite and the candida work in tandem to suppress the immune response.

9. Finally, other family members and pets can repeatedly reinfect a person with parasites. The whole family (including pets) must be treated if they are infected.

In my experience, the right set of frequencies, in the right order, for the right amount of time, in the right spot, with the right power transfer will always work. However, therein lies the conundrum. For almost every organism, and every strain of that organism, this may need to be determined for the specific case. There are some exceptions, some of the cancer frequencies, and the carpel tunnel frequency set, but otherwise, frequency sets are only good starting points for investigation in a specific context.

Even if the average clinician were able to overcome all of these issues, my conclusion after extensive experimentation is the the time it takes would not be financially viable in current clinical practice until the process can be largely automated. The good news is that I think it could be largely automated, but some signficant investment in diagnostic and treatment devices is required.

Cancer is a life threatening phenomenon and should be treated by a professional. However, tumors typically go through at least three pre-maligant phases, often over an entended time period of many years, where cancer frequencies may be detected. By eliminating all evidence of these frequencies in the body, a maliganant tumor may be avoided. The attached note shows one approach to this problem.

To: [email protected]

From: “jsutherland”

Date: Thu Aug 1, 2002 11:06 am

Subject: Comments on 11.7M frequencies

I’ve had the opportunity to test out the FSCAN and EM6+ on a variety of tumor types recently and found that pinpoint accuracy on the cancer frequencies is essential.

First, eliminating the 2008, 2127 organisms is essential to stop tumor growth and initiation of new tumors. The 2127 frequency is stable. However, it is often necessary to knock out strains of the organism at each frequency between 2003 and 2009 to eliminate all of it.

It appears that these organisms when confounded with parasite infections are very difficult to eliminate, as the parasites become infected and server as a recurrent source of infection. So sets of parasite frequencies may be essential.

Then I go to the 11.7M range. Here, I find a different specific frequency for each tumor and metastasis. Not having the exact frequency means you will not knock out the organism which behaves like a fungus. Since I am limited to the EM6+ and FSCAN I can only treat below 10000 with EM6+ and below 3M with the FSCAN. I treat every octave of the exact frequency in the treatement range of these devices until there is no detectable response.

This gives very good results on localized tumors, particlarly on the skin. Internal tumors are much more difficult to deal with.

In any event, the lack of exact frequencies is going to give very mixed results for different researchers using the 11.7M frequencies as they are much more highly variable than the 2008,2127 frequencies, yet appear to be essential to deal with for tumor elimination.

I have also experimented with multiple auxiliary modalities, many of which prove to be palliative and confirm a lot of folklore. Homeopathy I use in every case and seems to be essential at least to eliminate tumor mass, if not an essential part of curative process itself.

There are quite a number of unnecessary surgeries for appendicitis and they are not without risk. You can die from side effects, like nosocomial infections, which are much more virulent in hospital settings because hospital patients do not move around to reinfect others. They lie still and the nurses and doctors reinfect others. That means organisms which immobilize an individual are spread rapidly in a hospital, whereas in the wild, so to speak, the person would die without infecting very many other people. This has to do with rapid genetic evolution of strains of organisms causing more virulent strains to spread more widely in hospitals. In World War I, there were almost twice as many dead from this factor than the 10 million killed by enemy fire. More details and references on this later, but I digress …

FSCAN users need never get sick enough to find themselves in the emergency room where a doctor has to make a quick decision with insufficient information. Better to give you unnecessary surgery than have you die of appendicitis and get sued. Always ask for a scan first. The literature shows this substantially increases your odds of a correct diagnosis.

Take a microscopic slide of an appendix and put it on the FSCAN imprinter. Do a scan and it will preferentially pick up hits from the appendix. Then treat with the appendix slide on the imprinter and impedance will be better matched to tissue like an appendix causing more energy transfer to that tissue in your body. Periodic scanning and treating will signficantly reduce the risk of appendicitis, i.e. it should never get infected and hurt. If it does, better see your physician.

The placebo effect is an interesting and important phenomenon. Research in recent years show that every thought in the brain generates physiological effects. The effects can be as strong as powerful drugs. Much more research should be done on how to generate a good placebo effect in every patient with a harmless treatment.

When I was at Stanford working in biostatistics, every patient in the hospital was on a study because even those patients getting a placebo did better than patients not on a study. Every medical interaction should focus on generating a positive placebo effect in a patient, especially when it leads to avoidance of an invasive treatment like knee surgery.

Knee Surgery For Arthritis Is Ineffective, Study Finds

By Susan Okie

Washington Post Staff Writer

Thursday, July 11, 2002; Page A01

An operation performed about 300,000 times a year on U.S. patients with arthritis is completely ineffective, according to an unusual study that compared the procedure with phony surgery.

The study, by researchers at the Houston Veterans Affairs Medical Center, compared two versions of arthroscopic knee surgery for osteoarthritis with a placebo operation in which patients were given a sedative and received only small skin incisions. All patients reported reduced pain and better knee function, and there was no difference in outcome between those who had real surgery and those who got the placebo procedure.

SCIENTISTS FIND HIGH RATES OF CANCER, HEART DISEASE

By Barbara Feder Ostrov

Mercury News, Tue, Jul. 09, 2002

Scientists today will urge millions of American women taking hormone replacement therapy to avoid its long-term use because of unacceptably high rates of breast cancer and heart disease.

The recommendation comes as researchers halt a massive national study that examined the risks of a combination estrogen-progestin therapy used by an estimated 6 million U.S. women. While the therapy reduced the rate of hip fractures and colon cancer, it created disturbingly higher risks of breast cancer, heart disease, strokes and blood clots in the lungs — regardless of the women’s ethnicity, age or health concerns.

The trial, run by the National Institutes of Health and part of the large Women’s Health Initiative series of studies, was expected to continue until 2005. More than 16,000 post-menopausal women participating in the study, including about 1,450 in the Bay Area, were notified of its shutdown Monday.

“We needed to stop the trial to ensure the patients’ safety. We got the answer to benefits vs. risks much sooner than we expected, and the risks clearly outweigh the benefits,” said Dr. Marcia Stefanick, a Stanford professor and chairwoman of the Women’s Health Initiative steering committee

For maximum health, each person must take responsibility for working with their physician on treatment planning and they must research the medical literature themselves. It is not possible for their physician to know the latest information. Here is why:



40,000 pages a day of updated information is delivered to Harvard medical students by Caregroup CIO John Halamka. One of the medical school’s chief goals is to help students quickly and easily find the nuggets of information they need without sifting through mountains of resource material, Halamka says.

“More information is published every day in medicine than a doctor can read in a lifetime,” he says. “We are filtering all that information and, by creating this large Web infrastructure, delivering to the students just what they need for their current courses, along with some selected references on top of that.”

Making all relevant information available is a hefty task, Halamka says. “We deliver 40,000 pages of mobile content every day to about 350 active users of hand-held devices,” he says. Students are the heaviest users of the PDAs because they are tied up in classes all day with limited access to personal computers. Most medical school faculty access data via the Web from PCs located in their offices and hospital units, he adds.

Harvard Medical School provides the platform and software. Medical students are expected to purchase their own PDAs. The institution has arranged some pricing discounts, Halamka says, but requiring students to buy their own PDAs instills a sense of ownership in-and responsibility for-the hand-held devices.

We’ve known since the late 1970’s that vitamin supplements significantly impact cancer risk. That’s when I cofounded a Center for Vitamins and Cancer Research at the University of Colorado School of Medicine with Nobel Laureate Linus Pauling as a sponsor. Year after year since then, clinical and epidemiology studies have been published in the major journals documenting the case. Here is another one showing radically reduced risk of ovarian cancer with Vitamin C and E supplementation at levels higher than the US Recommended Daily Allowances:

Nutrition and Cancer 40:2, 2002

Aaron T. Fleischauer, Sara H. Olson, Laura Mignone, Neal Simonsen, Thomas A. Caputo, and Susan Harlap

Abstract

Several studies of dietary and serum antioxidant micronutrients (vitamins A, C, and E and beta-carotene) suggest that higher levels may be protective for ovarian cancer. None of these has examined supplements. We used a food frequency questionnaire and additional questions on supplements to study 168 histologically confirmed epithelial ovarian cancer cases, 159 community controls, and 92 hospital-based controls. Antioxidant consumption from diet or supplements was calculated in milligrams or international units per day. In multivariate analyses using only community controls, the highest levels of intake of vitamins C and E from supplements were protective: odds ratio (OR) = 0.40 [95% confidence interval (CI) = 0.21-0.78] and OR = 0.33 (95% CI = 0.18-0.60), respectively. Consumption of antioxidants from diet was unrelated to risk. In analyses combining antioxidant intake from diet and supplements, vitamins C ( 363 mg/day) and E ( 75 mg/day) were associated with reduced risks: OR = 0.45 (95% CI = 0.22-0.91) and OR = 0.44 (95% CI = 0.21-0.94), respectively. Results were similar, with some attenuation toward the null, in analyses combining both control groups. The levels of vitamins C and E associated with the protective effect were well above the current US Recommended Dietary Allowances. These findings support the hypothesis that antioxidant vitamins C and E from supplements are related to a reduced risk of ovarian cancer.

S Matsumoto, Y Imaeda, S Umemoto, K Kobayashi, H Suzuki and T Okamoto. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. British Journal of Cancer (2002) 86, 161 – 167.

Cimetidine has been shown to have beneficial effects in colorectal cancer patients. In this study, a total of 64 colorectal cancer patients who received curative operation were examined for the effects of cimetidine treatment on survival and recurrence. The cimetidine group was given 800 mg day71 of cimetidine orally together with 200 mg day71 of 5-fluorouracil, while the control group received 5-fluorouracil alone. The treatment was initiated 2 weeks after the operation and terminated after 1 year. Robust beneficial effects of cimetidine were noted: the 10-year survival rate of the cimetidine group was 84.6% whereas that of control group was 49.8% (P50.0001). According to our previous observations that cimetidine blocked the expression of E-selectin on vascular endothelium and inhibited the adhesion of cancer cells to the endothelium, we have further stratified the patients according to the expression levels of sialyl Lewis antigens X (sLx) and A (sLa). We found that cimetidine treatment was particularly effective in patients whose tumour had higher sLx and sLa antigen levels. For example, the 10-year cumulative survival rate of the cimetidine group with higher CSLEX staining, recognizing sLx, of tumours was 95.5%, whereas that of control group was 35.1% (P=0.0001). In contrast, in the group of patients with no or low levels CSLEX staining, cimetidine did not show significant beneficial effect (the 10-year survival rate of the cimetidine group was 70.0% and that of control group was 85.7% (P=n.s.)). These results clearly indicate that cimetidine treatment dramatically improved survival in colorectal cancer patients with tumour cells expressing high levels of sLx and sLa.

Life Extension Weekly Update, June 21 2002

The June 19 2002 issue of the Journal of the American Medical Association published Scientific Review and Clinical Applications articles sharing the title, “Vitamins for Chronic Disease Prevention in Adults“. The objective of the Scientific Review is to review the clinically important vitamins’ effects, sources, deficiency syndromes, toxicity, and relationship to chronic disease. The review of studies published from 1966 through 2001 on nine nutrients revealed a population consisting of the elderly, alcohol-dependent individuals, vegans, and those with malabsorption who are at risk of inadequate intake or absorption of several of these nutrients. The Clinical Applications article notes that although deficiency diseases such as scurvy and pellagra are rare, insufficient vitamin intake is a cause of chronic diseases, and that suboptimal levels of vitamins, even though these levels might be well above those classified as deficient, are risk factors for osteoporosis, cardiovascular disease and cancer.

The authors examined studies concerning the following nutrients: vitamins A, B6, B12, C, D, E and K, folate, and the carotenoids including alpha and beta-carotene, beta-cryptoxanthin, lycopene, lutein and zeaxanthin. They noted the association of low intakes of the B vitamins with elevated homocysteine levels and the corresponding increased risk of coronary heart disease disease; of low folate with neural tube defect, coronary heart disease and breast and colorectal cancer; of vitamin B6 deficiency with cheilosis, stomatitis, central nervous system effects and neuropathy; of low B12 with macrocytic anemia and neurologic abnormalities; of suboptimal vitamin E with prostate cancer; of low levels of various carotenoids with breast, prostate and lung cancer; of vitamin D with secondary hyperparathyroidism, bone loss, osteoporosis and increased fracture risk; of vitamin C with cancer in some studies, of vitamin A with vision disorders and decreased immune function, and of vitamin K with blood clotting disorders and possibly with increased fracture risk.

In the “Clinical Applications” article, Drs Fletcher and Fairfield conclude that a large proportion of the general population is at increased risk of cardiovascular disease, cancer, osteoporosis and other chronic diseases because of suboptimal vitamin levels. The high prevalence of these diseases indicates the standard diet in the U.S. fails to provide sufficient amounts of the vitamins studied. They write, “Pending strong evidence of effectiveness from randomized trials, it appears prudent for all adults to take vitamin supplements.” This is a significant move forward from the notion that all of one’s nutritional needs can be met by diet alone that the medical establishment has been advising for decades.